T-cell activation is an immune correlate of risk in BCG vaccinated infants (Q36799172)

16 August 2017

T-cell activation is an immune correlate of risk in BCG vaccinated infants (English)

1 reference

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants

16 August 2017

corrigendum / erratum

0 references

Helen A Fletcher

0 references

Wasima Rida

0 references

Willem Albert Hanekom

object named as

Willem A Hanekom

1 reference

16 August 2017

Thomas J Scriba

1 reference

16 August 2017

Gregory Hussey

1 reference

16 August 2017

Helen McShane

1 reference

16 August 2017

Thomas G Evans

1 reference

16 August 2017

Margaret A Snowden

1 reference

16 August 2017

Bernard Landry

1 reference

16 August 2017

Iman Satti

1 reference

16 August 2017

Stephanie A Harris

1 reference

16 August 2017

Magali Matsumiya

1 reference

16 August 2017

Rachel Tanner

1 reference

16 August 2017

Matthew K O'Shea

1 reference

16 August 2017

Veerabadran Dheenadhayalan

1 reference

16 August 2017

Leah Bogardus

1 reference

16 August 2017

Lisa Stockdale

1 reference

16 August 2017

Leanne Marsay

1 reference

16 August 2017

Agnieszka Chomka

1 reference

16 August 2017

Rachel Harrington-Kandt

1 reference

16 August 2017

Zita-Rose Manjaly-Thomas

1 reference

16 August 2017

Vivek Naranbhai

1 reference

16 August 2017

Elena Stylianou

1 reference

16 August 2017

Fatoumatta Darboe

1 reference

16 August 2017

Adam Penn-Nicholson

1 reference

16 August 2017

Elisa Nemes

1 reference

16 August 2017

Mark Hatheril

1 reference

16 August 2017

Hassan Mahomed

1 reference

16 August 2017

Michele Tameris

1 reference

16 August 2017

J Bruce McClain

1 reference

16 August 2017

language of work or name

English

0 references

publication date

12 April 2016

1 reference

16 August 2017

Nature Communications

1 reference

16 August 2017

1 reference

16 August 2017

11290

1 reference

Variation in the human immune system is largely driven by non-heritable influences

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85A

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

A rational vaccine pipeline for tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

The HIV-associated tuberculosis epidemic--when will we act?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Disseminated tuberculosis in interferon gamma gene-disrupted mice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

More powerful procedures for multiple significance testing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Do microbes with peptides mimicking myelin cause multiple sclerosis if the T cell response to their unique peptides is limited?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988-1994.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4832066

Expansion of the CD57 subset of CD8 T cells in HIV-1 infection is related to CMV serostatus

5 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS11290

Congenital cytomegalovirus (CMV) epidemiology and awareness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS11290

Efficiency Study of Estimators for a Treatment Effect in a Pretest–Posttest Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS11290

Humoral immune response in infants after BCG vaccination

21 January 2018

1 reference

12 December 2020

Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of

1 reference

12 December 2020

CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-α, IFN-γ, and sIL-2R levels in aging

1 reference

12 December 2020

T regulatory cells and immune activation in Mycobacterium tuberculosis infection and the effect of preventive therapy

1 reference

12 December 2020

Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency

1 reference

12 December 2020

A blood RNA signature for tuberculosis disease risk: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS11290

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NCOMMS11290

1 reference

Dimensions Publication ID

16 August 2017

0 references

0 references

1 reference

16 August 2017

PubMed publication ID

27068708

1 reference